MUSCLE INVASIVE BLADDER CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope to beat bladder cancer without surgery
Disease control OngoingThis study is testing a treatment approach for muscle-invasive bladder cancer that aims to avoid removing the bladder through major surgery. Participants receive a combination of chemotherapy, immunotherapy (toripalimab), and radiation therapy. The goal is to see if this non-surg…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Major trial aims to boost bladder cancer survival with Immune-Boosting drug
Disease control OngoingThis large, late-stage trial is testing whether adding an immunotherapy drug (atezolizumab) to the standard treatment of chemotherapy and radiation improves results for patients with muscle-invasive bladder cancer. The goal is to better control the cancer and help patients keep t…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Targeted drug combo tested to fight tough bladder cancer
Disease control TerminatedThis study aimed to see if a targeted pill (erdafitinib) alone or combined with an immunotherapy drug (atezolizumab) could shrink aggressive bladder tumors before surgery. It was for patients whose cancer had grown into the muscle wall of the bladder and who could not receive the…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New radiation tech aims to spare cancer patients from severe diarrhea
Symptom relief OngoingThis trial is testing a more precise, daily-adapted form of radiation therapy for muscle-invasive bladder cancer. The main goal is to see if this method causes fewer severe intestinal side effects, like diarrhea, compared to standard radiation. It involves 110 participants and fo…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC